Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen plus morphine for acute pain in sickle cell disease
2008-006846-24Phase 4Terminated
- Sponsor
- North West London Hospitals NHS Trust
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in sickle cell disease (SCD) comparing Ibuprofen + morphine PCA with Placebo + morphine PCA (2 arms). Primary endpoint: Morphine consumption over 4 days. Started Dec 2008; status: terminated.
02
Drugs
ibuprofen
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on 2008-006846-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006846-24.